Skip to main content

Table 7 Clinical data and pathological features of the 2 feline injection site sarcomas (FISSs) used for the establishment of primary cells

From: Investigating the role of signal transducer and activator of transcription 3 in feline injection site sarcoma

 

FISS-10

FISS-14 (NTU2018-1134)

Breed

Mixed

Mixed

Sex/Age(years)

Spayed female/10y

Castrated male/6y

Tumor size

<5cm

>5cm

Location

Left scapula

Left trunk

Pathological diagnosis

Sarcoma

Fibrosarcoma

Grading

II-III

II

cbIHC/daICC profile

  

 eSTAT3

2/+

2/+

fPhospho-STAT3 (Tyr705)

0/-

2/+

  1. aICC criteria: - = negative; + = more than 5% cells positive
  2. bIHC criteria: count 10 HPF for each section (at least 1000 cells), 0 = negative; 1 = less than 10% cells positive; 2 = 10-50% cells positive; 3 = more than 50% cells positive
  3. cIHC immunohistochemistry
  4. dICC immunocytochemistry
  5. eSTAT3 signal transducer and activator of transcription 3
  6. fPhospho-STAT3 (Try705) = signal transducer and activator of transcription 3 phosphorylated at tyrosine 705